Situated strategically within USF Research Park, the institute also functions as the Center of Excellence for the Global Virus Network (GVN), whose international headquarters are now co-located within the same premises. This co-localization creates a unique synergy, uniting virologists and infectious disease experts from over 40 countries in a collaborative environment conducive to rapid scientific advancement. The integration of the GVN amplifies the institute’s global outreach, facilitating multinational research endeavors and harmonized responses to emerging viral threats.

Dr. Gallo articulated the institute’s mission as one deeply intertwined with clinical medicine and public health. The research agenda prioritizes elucidating the molecular mechanisms underlying viral infections, immune system dysregulation, and oncogenesis driven by viral agents. By focusing on virus-associated cancers and the interplay between chronic viral infections like HIV and human immune dysfunction, the institute aims to bridge fundamental virological research with translational applications that directly affect patient care and therapeutic innovation.

A salient aspect of the institute’s work centers on the continued investigation into how HIV and human T cell leukemia virus type 1 (HTLV-1) contribute to chronic inflammation and subsequent malignant transformations. Despite the efficacy of antiretroviral therapies in suppressing viral loads, many individuals living with HIV are susceptible to comorbidities, including various cancers and immune-related complications. Through integrative studies encompassing virology, immunology, and oncology, the institute seeks to unravel these complexities, paving the way for novel interventions.

Beyond human retroviruses, researchers at the institute are delving into the oncogenic potential of bacterial pathogens and their role in developmental anomalies during fetal growth. This multifaceted approach reflects the institute’s commitment to understanding microbial contributions to cancer biology holistically. By dissecting underlying biological pathways, the institute aspires to translate these insights into effective diagnostic tools and treatment strategies that mitigate microbial-induced tumorigenesis.

Future initiatives will also tackle the public health challenges posed by respiratory viruses and mosquito-borne pathogens, which are particularly relevant to Florida’s diverse ecological zones. Leveraging cutting-edge genomic surveillance and computational outbreak modeling, the institute aims to enhance preparedness against epidemics and pandemics. Its One Health approach acknowledges the interconnectedness of human health, animal health, and environmental factors, thereby fostering comprehensive methodologies for disease control and prevention.

Collaboration is a cornerstone of the institute’s strategy. It maintains robust partnerships with Tampa General Hospital’s Cancer Institute, where Dr. Gallo directs the Microbial Oncology Program, allowing systematic progression of discoveries from laboratory research to clinical application. Additional alliances with renowned institutions such as Moffitt Cancer Center and global health organizations spanning Latin America, Africa, Europe, and Asia further cement the institute’s role as a nexus of international virology research and innovation.

From an economic perspective, the institute envisions catalyzing biotechnology entrepreneurship and workforce development within Florida. By integrating interdisciplinary academic departments—including the College of Public Health, Microbiomes Institute, and the Department of Internal Medicine—the institute endeavors to cultivate a new generation of skilled scientists adept at addressing viral and immune-related diseases. This educational emphasis strengthens the state’s biotechnology corridor, promoting high-skill job creation and technological advancement.

A critical element of the institute’s mandate involves establishing a comprehensive global viral surveillance infrastructure. This system will harness advancements in laboratory technology, pathogen genomics, and real-time public health data analytics. The goal is to facilitate rapid detection of emerging viruses and improved response coordination on a global scale, thereby augmenting pandemic resilience not only in Florida and the U.S. but worldwide.

The University of South Florida, recognized for its ascending research profile and as a member of the elite Association of American Universities, stands to bolster its institutional prestige via this visionary endeavor. USF President Rhea Law highlighted the transformative potential the institute holds to elevate USF’s global standing and magnify its research impact, while fostering innovations that tangibly enhance human health across nations.

Dr. Gallo’s appointment as the founding director brings unparalleled expertise drawn from his decades-long career breakthrough achievements, including development of the first HIV blood test, discovery of interleukin-2 that enabled T cell culture, and seminal work facilitating cellular immunotherapies like CAR T-cell therapy. His leadership underscores a commitment to pioneering virology research grounded in pragmatic clinical application and public health relevance.

As the Institute for Translational Virology and Innovation embarks on its mission, it embodies a paradigm shift—melding fundamental and translational science with global collaboration and innovation. The endeavor promises to generate critical insights into viral pathogenesis, accelerate therapeutic discovery, and enhance global preparedness against viral pandemics. This initiative not only symbolizes scientific progress but also embodies a strategic investment in public health infrastructure, economic vitality, and educational excellence in the realm of virology.

Subject of Research: People

Article Title: USF Launches Institute for Translational Virology and Innovation Under HIV Pioneer Dr. Robert Gallo

News Publication Date: October 30, 2025

Web References:

• USF Health: https://health.usf.edu/
• Global Virus Network: https://health.usf.edu/medicine/internalmedicine/infectious/global-virus-network
• University of South Florida: http://www.usf.edu/

Image Credits: USF Health

Keywords: Virology, Cancer, Viruses, Pathogens

The Rising Star Mentorship Program distinguishes itself by offering a comprehensive two-year curriculum that combines direct mentorship with progressive independence. During the initial year, each awardee is paired with an eminent mentor from one of GVN’s global Centers of Excellence or Affiliates, facilitating personalized guidance and collaborative engagement. In the subsequent year, the program encourages awardees to apply their knowledge autonomously, fostering scientific independence and research innovation. Integral to the program’s structure is a seed research grant of up to $10,000, which empowers recipients to initiate or expand critical virological studies, alongside financial support to participate in GVN meetings, enhancing their exposure to the global scientific community.

Dr. Sten Vermund, MD, PhD, Chief Medical Officer of GVN and Dean of the University of South Florida College of Public Health, emphasized the strategic urgency of this investment in emerging virologists. “Emerging infectious diseases remain a paramount challenge to global health,” he noted. “By nurturing a new generation of scientists equipped with cutting-edge skills and a global perspective, we can mitigate the impact of viral outbreaks more effectively. The scarcity of qualified virologists in resource-limited settings threatens rapid response capacities; this program is a critical step toward addressing that shortfall.”

The 2025 cohort reflects the program’s commitment to geographic diversity and interdisciplinary excellence. Dr. Abdou Padane of Senegal, a medical biologist and biosafety level 3 facility manager at the Institute for Health Research – Epidemiological Surveillance and Training (IRESSEF), brings invaluable expertise in genomic surveillance and laboratory capacity building. Under the mentorship of Dr. Claudia Filippone from Belgium’s ERINHA, Abdou’s work epitomizes how strengthening lab infrastructures in West Africa can substantially enhance outbreak preparedness and real-time pathogen tracking.

In the United States, Dr. Gage Moreno, a postdoctoral fellow at the Broad Institute of MIT and Harvard, focuses on integrating field epidemiology with molecular virology to refine outbreak response strategies. His mentor, Dr. Emily Gurley of Johns Hopkins Bloomberg School of Public Health, highlighted the translational potential of Moreno’s research, noting, “His vision bridges academic inquiry and tangible public health interventions, which is crucial for timely epidemic management.”

Australia’s contribution to the roster is Dr. Hannah King, a research fellow at the Peter Doherty Institute for Infection and Immunity. Her cutting-edge studies at the intersection of virology and immunomodulation aim to unlock novel therapeutic avenues in the quest for an HIV cure. Guided by Dr. Howard Gendelman of the University of Nebraska Medical Center, her research endeavors promise to translate molecular insights into clinical breakthroughs that could reshape HIV treatment paradigms globally.

Dr. Irene Amoakoh Owusu, a postdoctoral associate at the West African Center for Cell Biology of Infectious Pathogens (WACCBIP) at the University of Ghana, exemplifies region-centric innovation. Mentored by Dr. Nokukhanya Msomi from South Africa’s University of KwaZulu-Natal, Irene’s focus on virology training and diagnostics aims to build sustainable scientific capacity in Africa, addressing endemic and emerging infections through localized expertise and infrastructure development.

Zimbabwe’s Dr. Vurayai Ruhanya, a virology lecturer at the University of Zimbabwe Faculty of Medicine and Health Sciences, completes the cohort with his work in genomic surveillance—a vital tool for early pathogen detection. His mentor, Dr. Christian Happi, a distinguished professor affiliated with Redeemer’s University and Harvard T.H. Chan School of Public Health, emphasized the integrative impact of Ruhanya’s research in deploying genomic technologies within public health frameworks to enhance disease monitoring and outbreak containment.

The orientation event marking the launch of the 2025 cohort brought together awardees, mentors, and GVN leadership in a virtual forum to establish mentorship goals and familiarize participants with collaborative tools essential for cutting-edge virological research. This collaborative nexus fosters cross-pollination of ideas, encouraging awardees to devise innovative strategies that confront the ongoing deficit of virologists, particularly in low- and middle-income countries, thereby amplifying the global response to viral threats.

GVN’s strategic emphasis on collaborative networks across seven countries encapsulates a unified global approach to confronting viral diseases. The organization’s model integrates education, training, rigorous research, and strategic health solutions, positioning its Rising Star Program at the forefront of building a resilient virology workforce capable of responding to evolving viral pathogens with agility and scientific rigor.

With viral outbreaks becoming more frequent and complex due to factors such as climate change, global travel, and urbanization, the role of virologists extends beyond laboratory research. The multifaceted expertise nurtured by GVN’s program encompasses pathogen genomics, bioinformatics, immunology, epidemiology, and public health implementation science. This holistic training prepares scientists not only to decode viral mechanisms but also to translate data into actionable public health policies and interventions.

The importance of personalized mentorship cannot be overstated. Through close mentorship relationships, early-career scientists gain the technical acumen and strategic insights necessary to navigate funding landscapes, scientific communication, and collaborative research. The 2025 Rising Stars benefit from direct access to senior scientists who are leaders in their respective disciplines, underlining GVN’s model of mentoring as a driving force in scientific innovation and leadership development.

As viral threats continuously transcend borders, GVN’s Rising Star Mentorship Program exemplifies a proactive, global endeavor ensuring that the next generation of virologists is well-equipped to respond swiftly and effectively. This initiative not only advances individual careers but also strengthens the collective capacity to safeguard global health in an era rife with viral uncertainties.

For interested parties seeking to support or learn more about this landmark program, direct engagement with GVN offers an avenue to contribute to the continued evolution of virology training and research—an investment that promises widespread benefits for global infectious disease prevention and control.

Subject of Research:
Early-career virologists’ mentorship and capacity building in pandemic preparedness and infectious disease research.

Article Title:
Global Virus Network Unveils 2025 Rising Star Mentorship Program Awardees: Empowering the Next Generation of Virologists

News Publication Date:
August 27, 2025

Web References:

• Global Virus Network: https://gvn.org
• Institute for Health Research – Epidemiological Surveillance and Training (IRESSEF)
• ERINHA (European Research Infrastructure on Highly Pathogenic Agents)

Keywords:
Virology, Pandemic Preparedness, Infectious Diseases, Mentorship Program, Early-Career Scientists, Genomic Surveillance, Viral Outbreak Response, Global Health, Research Training, Molecular Virology, Immunomodulation, HIV Cure Research

Dr. Sten Vermund, GVN’s Chief Medical Officer and Dean of the University of South Florida College of Public Health, eloquently emphasized the urgency of a united scientific front. “Intellectual prowess throughout the Caribbean and Latin America is remarkable; however, intellectual strength alone will not shield us from impending pandemics,” he asserted. Dr. Vermund underscored the necessity of forging bridging collaborations transcending linguistic, geopolitical, and disciplinary divides. Ahead of an era marked by escalating global temperatures and vector proliferation, the meeting stressed that viruses do not respect borders—whether in Tampa or Kingston, common vectors such as mosquitoes facilitate similar threats, mandating a cohesive and synchronized response rooted in interdisciplinary cooperation.

Representatives from regional research institutions expressed the indispensable role of local expertise in combating viral threats with global ramifications. Among them, Dr. John Lindo, a professor at UWI Mona, highlighted the persistent endemic pressures of arboviruses including dengue and chikungunya, alongside retroviruses such as Human T-cell Leukemia Virus (HTLV) and HIV. Reflecting on UWI’s commitment spanning decades, Dr. Lindo advocated for intensified partnerships, declaring that institutional capacities must be leveraged collectively, a sentiment echoed across this gathering. The university’s network across 18 Caribbean territories symbolizes a critical intellectual and infrastructural backbone that must interface with international partners to effectively confront these viral challenges dynamically.

Amid discussions on infrastructural evolution, Dr. Calum MacPherson from St. George’s University in Grenada presented insights into transformative progress instigated post-COVID-19. The university’s rise to national prominence as Grenada’s principal reference laboratory underpins an emergent paradigm where investment in research capabilities yields robust platforms for febrile illness analysis. Dr. MacPherson revealed that while dengue accounts for about 20% of febrile cases studied locally, a substantial proportion—approximately 80%—remains diagnostically elusive, signifying significant gaps in viral identification and necessitating broader research pipelines.

Further emphasizing viral oncology intersections, Dr. Eduardo Gotuzzo of Peru’s Institute of Tropical Medicine brought to light the intimate connections between viral infections and cancer incidence, particularly with HTLV-1 in marginalized demographics. Stressing equitable partnership models, he advocated for an ethical science framework where resource sharing transcends mere sample exchange and encompasses comprehensive knowledge co-creation. His call spotlights a critical paradigm shift necessary for low- and middle-income countries (LMICs) to be genuine collaborators in the global scientific enterprise, bolstering surveillance capacities for respiratory viruses and complex co-infections otherwise underrepresented in global datasets.

Technological advances took center stage during a dynamic panel session highlighting the fusion of artificial intelligence, microbiome studies, wastewater epidemiology, and climate data as synergistic tools to fortify pandemic readiness. Cutting-edge methods employing predictive modeling of influenza outbreaks demonstrated how integrating environmental parameters with real-time genomic sequences obtained from wastewater can enable anticipatory public health interventions. Discussions underscored climate change as a catalytic driver enhancing arboviral transmission in diverse ecological niches, from Brazil’s tropical regions to mountainous Andean ecosystems, thereby emphasizing the necessity for regionally coordinated, multi-disciplinary approaches combating these entangled biosphere-human health challenges.

Contributing industry-led perspectives, Dr. Lester Perez of Abbott Laboratories shared progress within the Abbott Pandemic Defense Coalition (APDC), a GVN Center of Excellence. APDC’s identification of 24 novel viruses and comprehensive training of over 120 field researchers showcase remarkable strides in viral discovery and field epidemiology. Of particular concern is the discovery of a novel yellow fever strain in Colombia genetically linked to a 1999 Bolivian lineage, bearing potential implications for vaccine efficacy due to possible immune escape traits. Dr. Perez cautioned on the imperative for proactive genomic surveillance infrastructure, asserting that without such vigilance, public health systems risk perpetual lagging behind emergent viral threats.

In an exemplary demonstration of integrated viral genomics, Dr. Christine Carrington from UWI St. Augustine delineated her team’s use of high-throughput sequencing to map viral evolution across interconnected human, animal, and vector populations. This holistic “One Health” approach builds robust frameworks for real-time outbreak detection and response, with viral phylogenomics tracing transmission pathways and enabling targeted containment strategies. Dr. Carrington’s leadership in this domain earned her the inaugural GVN Regional Excellence in Leadership Award, signifying a regional hallmark in scientific innovation and collaborative leadership.

Latin America’s burgeoning vaccine research and development landscape was spotlighted by Dr. Arlene Calvo of the University of South Florida College of Public Health. Her presentation underscored Panama’s ascendancy as a vaccine innovation hub, attributed to its comprehensive public health infrastructure, entrenched community trust, and pioneering initiatives such as the National Vaccine Research Center. Collaborations with institutions like INDICASAT-AIP and the Gorgas Memorial Institute further position Panama as a powerhouse of vaccine pipeline generation within the region, with Dr. Calvo emphasizing the integral role of multidisciplinary research ecosystems in catalyzing translational breakthroughs.

Wastewater-based epidemiology (WBE) emerged as a compelling surveillance modality with significant predictive potential. Dr. Helena Solo-Gabriele of the University of Miami highlighted how expanded applications of WBE extend beyond COVID-19 to encompass respiratory pathogens, multidrug-resistant fungi such as Candida auris, Mpox, poliovirus, and notably dengue virus. These efforts leverage synergistic collaborations with Miami-Dade County Mosquito Control and the University of Miami Miller School of Medicine, epitomizing a model where engineering, microbiology, and public health intersect to monitor pathogen circulation at granular community levels, thereby informing timely intervention measures prior to clinical outbreak confirmations.

Addressing arboviruses’ climatic interconnections, Dr. Scott Weaver of the University of Texas Medical Branch articulated concerns over alarming trends among dengue, chikungunya, and Western equine encephalitis viruses in the Americas. He underscored the stealthy spread of emerging agents like the Oropouche virus in rural settings where surveillance is markedly inadequate. Genomic studies reveal virulent new variants, yet limited data and funding undermine comprehensive understanding and public health response. Dr. Weaver stressed the critical necessity of augmenting surveillance intensity to detect and characterize these under-recognized but potentially impactful viral threats.

At the crossroads of research sustainability and regional capacity building, SUNY Distinguished Professor Dr. Gene Morse of the University of Buffalo outlined a multidisciplinary training framework essential for advancing virology in LMICs. His model integrates genomics, immunology, pathogen-vector-host dynamics, and clinical outcomes into a cohesive system requiring sustained investment and mentorship. Dr. Morse praised initiatives like the NIH Fogarty International Center’s Global Infectious Disease Research Training program while underscoring the importance of inclusive participation from industry and philanthropic sectors to nurture the next generation of virologists capable of bridging scientific discovery with practical health solutions.

Reflecting on vaccinology’s duality of historic successes and unmet challenges, Dr. Sten Vermund revisited the transformative impact of vaccines on diseases like polio and smallpox while signaling persistent gaps, especially with pathogens such as herpes simplex virus-2, HTLV-1, and emerging arboviruses. He challenged public health authorities to reframe vaccines not solely as infection blockers but as critical tools mitigating disease severity, curtailing transmission, and preserving population health. Dr. Vermund’s appeal highlighted equity in vaccine delivery as paramount, asserting that scientific advances bear limited impact unless matched by accessible and equitable immunization strategies—underscoring delivery as the linchpin of vaccine efficacy.

The regional meeting culminated by honoring Dr. Christine Carrington with the GVN Regional Excellence in Leadership Award, celebrating her groundbreaking contributions to viral genomics and her pivotal role in enhancing the Caribbean’s preparedness for viral pandemics. Dr. Vermund lauded Dr. Carrington as a beacon guiding collaborative science efforts confronting formidable viral challenges, reflecting the broader ethos of the meeting which championed integrated, cross-sectoral approaches to global health security.

Looking forward, the Global Virus Network announced forthcoming engagements to sustain momentum, including the GVN Short Course in Translational Virology scheduled for December 3-12, 2025, and the GVN Annual Scientific Meeting set for March 4-6, 2026, both hosted in Tampa, Florida. These events aim to further expand interdisciplinary collaboration, capacity building, and innovation in viral research, continuing the mission to protect global health amidst evolving infectious disease landscapes.

The 2025 GVN Regional Meeting: Caribbean and Latin America was graciously supported by the CDC Foundation, USF Health, and the University of South Florida College of Public Health. For comprehensive details on the meeting’s program and scientific contributions, readers are encouraged to visit the official GVN webpage dedicated to the event.

Subject of Research: Viral surveillance, diagnostics, vaccine research, pandemic preparedness, and the impact of climate change on viral transmission in the Caribbean and Latin America.

Article Title: The 2025 Global Virus Network Regional Meeting: Strengthening Viral Research and Pandemic Resilience in the Caribbean and Latin America

News Publication Date: May 8, 2025

Web References:

• https://gvn.org/
• https://gvn.org/gvn-2025-jamaica/
• https://gvn.org/activities/nurture/
• https://gvn.org/activities/meetings-and-events/
• https://www.mona.uwi.edu/
• https://sta.uwi.edu/
• https://www.cavehill.uwi.edu/home
• https://fiveislands.uwi.edu/
• https://global.uwi.edu/
• http://www.uwi.edu

Keywords: Virus surveillance, arboviruses, pandemic preparedness, viral genomics, vaccine research, wastewater epidemiology, climate change and viral transmission, Caribbean virology, Latin American infectious diseases, global health, viral diagnostics, virus evolution.